Dalton, GB
Colette Dalton, Glasgow GB
Patent application number | Description | Published |
---|---|---|
20150055132 | METHOD FOR CALIBRATING SPECTROSCOPY APPARATUS AND EQUIPMENT FOR USE IN THE METHOD - This invention concerns a method of calibrating spectroscopy apparatus including illuminating a reference sample, identifying spectrum from light emitted from the sample and calibrating the spectroscopy apparatus based upon the spectrum, wherein the reference sample has been dried. The invention also concerns a reference sample for use in this method and a kit including such a reference sample. The reference sample may be lyophilised dye labelled oligonucleotides. | 02-26-2015 |
Gregory Dalton, Southampton GB
Patent application number | Description | Published |
---|---|---|
20080256145 | Apparatus for Migrating Data Between Heterogeneous Data Storage Devices - A method for migrating data between heterogeneous data storage devices within a storage area network is disclosed. A first virtualizer presents stored data as a first virtual disk, and then communicates a managed disk representation of the first virtual disk to a second virtualizer. After receiving the managed disk representation, the second virtualizer virtualizes the stored data from the managed disk representation as a second virtual disk. At such point, the stored data can be progressively migrated from the first virtualizer to the second virtualizer. | 10-16-2008 |
Harry R. Dalton, Bodmin GB
Patent application number | Description | Published |
---|---|---|
20130302790 | INFECTIOUS HEPATITIS E VIRUS GENOTYPE 3 RECOMBINANTS - The invention relates to the discovery of an HEV strain from a chronically infected patient. The virus grow unusually well in numerous cell cultures. Thus, the invention provides cell cultures, vectors, and vaccine compositions based on the virus. The invention relates, in part, on the identification of a new strain of HEV genotype 3 virus. Strain Kernow-C1 (genotype 3) of HEV, which was isolated from a chronically infected patient, was used to identify human, pig and deer cell lines permissive for infection. Adaptation of the Kernow-C 1 strain to growth in human hepatoma cells selected for a rare virus recombinant that contained an insertion of 174 ribonucleotides (58 amino acids) of a human ribosomal protein gene and additional mutations. | 11-14-2013 |
James Spencer Dalton, Berkshire GB
Patent application number | Description | Published |
---|---|---|
20090203518 | CATALYST ADDITIVES - A nickel slurry comprising a nickel catalyst, water and at least one rheology modifier, the activity of the nickel catalyst being equal to or greater than the activity of the equivalent nickel catalyst contained in a slurry which does not comprise rheology modifiers, wherein the at least one rheology modifier provides high viscosity at low shear stress and low viscosity at high shear stress. | 08-13-2009 |
James Spencer Dalton, Reading GB
Patent application number | Description | Published |
---|---|---|
20100280274 | CATALYST ADDITIVES - A nickel slurry comprising a nickel catalyst, water and at least one rheology modifier, the activity of the nickel catalyst being equal to or greater than the activity of the equivalent nickel catalyst contained in a slurry which does not comprise rheology modifiers, wherein the at least one rheology modifier provides high viscosity at low shear stress and low viscosity at high shear stress. | 11-04-2010 |
Joan Dalton, Elstree Hertfordshire GB
Patent application number | Description | Published |
---|---|---|
20110021418 | ENRICHED HAPTOGLOBIN POLYMERS FOR THE TREATMENT OF DISEASE - Haptoglobin (Hp) removes cell-free Hemoglobin (Hb), with different physiological effects depending on the particular Hp polymer. We propose that material enriched for alpha 1 chain Hp polymeric forms, such as those made from Cohn fraction V precipitate, will be more suitable for the treatment of certain diseases benefiting from both an antioxidant and anti-inflammatory component, such as for hemolytic disease. Material enriched for alpha-2 chain Hp polymeric forms, made for example from Cohn fraction IV precipitate, will be more suitable for treatment of diseases where an angiogenic, and/or inflammatory affect, and/or limited extravasation is desirable. | 01-27-2011 |
Joan Dalton, Hertfordshire GB
Patent application number | Description | Published |
---|---|---|
20090292114 | METHOD FOR THE PURIFICATION OF ALPHA-1-ANTITRYPSIN - The invention relates to methods for the isolation of AAT from solutions containing albumin and AAT using at least two separate metal chelate chromatography steps. The product may be further purified and/or subjected to one or more virus inactivation or reduction steps. The isolated AAT may then be formulated for pharmaceutical use. | 11-26-2009 |
Joan Dalton, Elstree GB
Patent application number | Description | Published |
---|---|---|
20090281282 | METHOD FOR THE ISOLATION OF HAPTOGLOBIN - The invention provides a method for the isolation of haptoglobin from a sample comprising Cohn fraction V, wherein said method comprises anion exchange chromatography of said sample. The product may be further purified and/or subjected to one or more virus inactivation or reduction steps. The isolated haptoglobin may then be formulated for pharmaceutical use. | 11-12-2009 |
Joan Dalton, Berkhampsted Herts GB
Patent application number | Description | Published |
---|---|---|
20080293623 | ENRICHED HAPTOGLOBIN POLYMERS FOR THE TREATMENT OF DISEASE - Haptoglobin (Hp) removes cell-free Hemoglobin (Hb), with different physiological effects depending on the particular Hp polymer. We propose that material enriched for alpha 1 chain Hp polymeric forms, such as those made from Cohn fraction V precipitate, will be more suitable for the treatment of certain diseases benefiting from both an antioxidant and anti-inflammatory component, such as for hemolytic disease. Material enriched for alpha-2 chain Hp polymeric forms, made for example from Cohn fraction IV precipitate, will be more suitable for treatment of diseases where an angiogenic, and/or inflammatory affect, and/or limited extravasation is desirable. | 11-27-2008 |
Jude Dalton, Nottingham GB
Patent application number | Description | Published |
---|---|---|
20080317310 | Method and system for image processing and assessment of blockages of heart blood vessels - One embodiment discloses a computerized method of assessing deposits and/or blockages in blood vessels in a human, specifically in a human heart. The method may include inputting patient data and creating a computerized interactive model of a heart based on the patient data. Patient data may include a plurality of images of a least a portion of a human heart. Images may include three-dimensional images. An image may be divided into regions. A property of a region may be assessed. A property may include intensity of brightness of a region or a portion of a region. A region may include one or more voxels or one or more pixels. A method may include comparing a property of a region of a heart from a first image to a second image. The first image and the second image may include equivalent regions acquired during different time periods. | 12-25-2008 |
Justin Dalton, Etwall GB
Patent application number | Description | Published |
---|---|---|
20130160460 | RIGID RAFT - The present invention provides a rigid raft formed of rigid composite material. The raft has an electrical system and/or a fluid system embedded therein. The raft further has a tank for containing liquid integrally formed therewith. The tank can be formed of the rigid composite material. The tank can be for a gas turbine engine. | 06-27-2013 |
Justin Sean Dalton, Derby GB
Patent application number | Description | Published |
---|---|---|
20140165531 | HEATED RIGID ELECTRICAL SYSTEM - A rigid electrical raft has electrical conductors embedded in a rigid material. The electrical conductors transmit electrical signals through the rigid electrical raft, which may form part of an electrical system of a gas turbine engine. The rigid electrical raft also has electrical heating elements embedded therein. The electrical heating elements provide heat which may be used, for example, to prevent condensation and/or ice build-up and/or to raise the temperature of electrical components to be within a desired range. | 06-19-2014 |
20140290271 | MOUNTING ARRANGEMENT - A rigid electrical raft is provided to a gas turbine engine via a fusible mount arrangement. The rigid electrical raft may be a part of an electrical system of the gas turbine engine, for example a part of the electrical harness. The fusible mount is arranged to break when a predetermined load is applied. The rigid electrical raft may be attached to a fan case of the engine, and the predetermined load may that which results from a fan blade being released from the hub. This ensures that the rigid electrical raft is protected from the load. | 10-02-2014 |
Martin Walter Dalton, Solihull GB
Patent application number | Description | Published |
---|---|---|
20120001114 | SHUT-OFF VALVE - This invention relates to a shut-off valve, and primarily to a valve for shutting-off the flow of a fluid such as a mains water supply to commercial premises or a domestic dwelling. The shut-off valve ( | 01-05-2012 |
Peter Dalton, Herts GB
Patent application number | Description | Published |
---|---|---|
20100125654 | Method and Apparatus for Utilizing User Identity - In accordance with an example embodiment of the present invention, an apparatus, comprising a processor configured to receive an input operation related to selecting at least a part of information related to a first user identity and at least a part of information related to a second user identity, utilize information related to the first user identity based at least in part on the input operation, and utilize information related to second user identity based at least in part on the input operation is disclosed. | 05-20-2010 |
Raymond Neil Dalton, London GB
Patent application number | Description | Published |
---|---|---|
20080280345 | Screening Method - The present invention relates to a method for screening for variant peptides using mass spectrometry (MS). The present invention also relates to a system and a kit for performing the method. | 11-13-2008 |
20100159473 | Peptide Standards - The invention relates to methods for making a peptide standard for mass spectrometry said method comprising (a) identifying endopeptidase cleavage sites in a parent polypeptide sequence of interest; (b) selecting peptide sequences from said parent polypeptide which are defined by endopeptidase cleavage sites of step (a); (c) adding a C-terminal extension to each selected sequence; wherein if the endopeptidase cleavage site is C-terminal to its recognition sequence then the C-terminal extension comprises 1 to 6 amino acids, wherein if the endopeptidase cleavage site is N-terminal to its recognition sequence then the C-terminal extension comprises said recognition sequence, wherein if the endopeptidase cleavage site is within its recognition sequence then the C-terminal extension comprises the remainder of said recognition sequence C-terminal to the cleavage site; and (d) synthesising a peptide having the extended amino acid sequence of step (c). The invention also relates to peptide standards and methods of analysing samples. | 06-24-2010 |
20100273199 | Methods and Compositions - The invention relates to a method for aiding the diagnosis of a disorder in a subject, said method comprising; providing a sample from said subject wherein the sample comprises blood; assaying at least two characteristics of said sample, said characteristics selected from: the structural composition of a polypeptide comprised by said sample; a metabolite comprised by said sample; and a catalytic activity comprised by said sample, wherein each of said at least two characteristics is determined from a multiplexed analysis of the same sample. The invention also relates to certain compositions. | 10-28-2010 |
20140212906 | Screening Method - A method for screening for variant peptides uses mass spectrometry (MS). A system and a kit may be used for performing the method. Proteins in a sample are digested to form a defined series of peptides. The defined series of peptides are ionized. The ionized species are subjected to collision induced dissociation. Species of known mass/charge ratio are detected to confirm the presence of the protein variant in the original sample. | 07-31-2014 |
Roger Patrick Dalton, Hampshire GB
Patent application number | Description | Published |
---|---|---|
20090003133 | Acoustic Telemetry - A method of transmitting data acoustically through a tubular structure, such as a drill string or production tubing in an oil or gas well, predominantly comprising a series of tubing sections ( | 01-01-2009 |